Clinical Trial Update: Computerized HIV/Sexually Transmitted Disease (STD) Prevention Program [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update of a computerized HIV/STD prevention program conducted by the University of North Carolina, Chapel Hill.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infections

Drugs mentioned

• Computerized HIV/STD Prevention Program

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Acquired Immunodeficiency Syndrome, HIV Infections | Phase 2 | Status: COMPLETED